Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease

NCT01562574 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Acquired Bleeding Disorder
Cardiac Surgery Requiring Cardiopulmonary Bypass

Interventions

DRUG: activated recombinant human factor VII
DRUG: placebo

Sponsor

Novo Nordisk A/S